Smith Brendan

CIK 00018574922 companiesLEXINGTON, MA

Transactions

Companies

Filings

CIK

0001857492

Recent Transactions

14 trades

Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2023-02-21$48.26/sh−1,392→ 5,072 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2023-02-18−3,825→ 11,475 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2023-02-18+3,825→ 6,464 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2022-10-17$55.76/sh−1,111→ 2,639 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2022-10-14+3,750→ 3,750 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2022-10-14+3,750→ 11,250 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-10-07+14,000→ 14,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2022-08-16+10,000→ 10,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-02-18+30,000→ 30,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2022-02-18+15,300→ 15,300 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-10-14+90,000→ 90,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2021-10-14+15,000→ 15,000 total
Sale
Translate Bio, Inc.
Stcok Option (right to buy)
2021-09-14−201,800→ 0 total
Award
Translate Bio, Inc.
Stock Option (Right to Buy)
2021-04-19+201,800→ 201,800 total

C/O TRANSLATE BIO, INC. 29 HARTWELL AVE

LEXINGTON, MA, 02421